| AMG Stock | | | EUR 255.75 24.10 8.61% |
Insider
Robert Bradway is CEO Chairman of Amgen Inc
| Age | 60 |
| Phone | 805 447 1000 |
| Web | https://www.amgen.com |
Amgen Management Efficiency
The company has return on total asset
(ROA) of
0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.
Amgen Inc has accumulated 37.35
B in total debt with debt to equity ratio
(D/E) of 3.98, implying the company greatly
relies on financing operations through barrowing. Amgen Inc has a current ratio of 1.28, suggesting that it
is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Amgen until it has trouble settling it off, either with new capital or with free cash flow. So, Amgen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amgen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amgen to invest in growth at high rates of return. When we think about Amgen's use of debt, we should always consider it together with cash and equity.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 24300 people. Amgen Inc (AMG) is traded on Frankfurt Exchange in Germany and employs 25,200 people.
Management Performance
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Linda Louie, VP Officer | |
| Robert Bradway, CEO Chairman | |
| Peter Griffith, Ex CFO | |
| Murdo Gordon, Ex Operations | |
| Dagmar Bottenbruch, Independent Member of the Supervisory Board | |
| Donatella Ceccarelli, Independent Member of the Supervisory Board | |
| Nancy Grygiel, Sr Officer | |
| Willem Hassel, Independent Vice Chairman of the Supervisory Board | |
| Frank Lohner, Independent Member of the Supervisory Board | |
| Herbert Depp, Independent Member of the Supervisory Board | |
| Steve Hanke, Independent Chairman of the Supervisory Board | |
| Jackson Dunckel, Member of the Management Board, Chief Financial Officer | |
| Michele Fischer, Vice President IR Contact Officer | |
| Esteban Santos, Ex Operations | |
| Heinz Schimmelbusch, Chairman of the Management Board, Chief Executive Officer | |
| Eric Jackson, Member of the Management Board and Presidentident of the AMG Processing Division, COO | |
| Jonathan Graham, Gen VP | |
| Mike Zahigian, VP Officer | |
| David MD, Ex RD | |
| Arvind Sood, VP Relations | |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.